Sermorelin Acetate (10mg)

GHRH (1-29) amide, the shortest fully active GHRH fragment. Comprising the opening 29 residues of human GHRH, sermorelin represents the briefest sequence that still retains the parent hormone's full activity at the receptor. For a period it held registration in several countries as a diagnostic agent and a paediatric growth therapy, and although it was later pulled from the market commercially, it continues to serve as a benchmark GHRH analogue in laboratory work.

GHRH receptor reference: a comparison baseline against which modified analogues are measured. GH-deficiency research: a track record as a diagnostic stimulation agent. Sleep and cognition: slow-wave sleep and executive function during ageing. Its pharmacological profile was mapped out during the 1990s through clinical application as a test for GH deficiency and as a therapy for growth-hormone deficiency in children. Subsequent research turned to its influence on sleep patterns and cognition among older adults (Baker et al., Arch Neurol 2012).

GH release in humans was documented through diagnostic and paediatric application; a separate study in older adults reported gains in cognition and sleep measures across 20 weeks.

During its clinical use the principal events were reactions at the injection site, flushing and headache, and it held a registered-product safety record up to the point it was withdrawn for commercial rather than safety reasons.

The published Sermorelin Acetate abstracts we cite do not state the amounts used, so there is no study figure to report. Peptide Aus supplies Sermorelin Acetate for in-vitro laboratory research and does not give dosing, cycle or usage guidance for people. The reconstitution section on this page covers how the vial is prepared.

Works at a different receptor, and the two are frequently combined for the same rationale that applies to CJC-1295.

Mod GRF 1-29 is essentially sermorelin carrying stabilising substitutions, with the DAC version extending duration.

The stabilised GHRH analogue that comes with visceral-fat outcome data behind it.

Add about 2 mL of bacteriostatic water slowly down the inside of the vial and swirl gently; do not shake. 10mg in 2 mL gives 5 mg/mL. Refrigerate at 2–8 °C after reconstitution and use within 8–12 weeks. The calculator has this vial preset.

Lyophilised: −20 °C, sealed, away from light and moisture. Reconstituted: 2–8 °C, used within 8–12 weeks, never frozen.

In Australia, Sermorelin Acetate holds no Therapeutic Goods Administration (TGA) registration as a medicine and carries no approval for use in humans or animals. The material is offered by Peptide Aus strictly as a research reagent intended for in-vitro laboratory work. The Poisons Standard and the Therapeutic Goods Act set the rules for supplying any substance for human use in this country, and lawful use of the material rests with the buyer. Anyone seeking treatment should consult a doctor.

Directly from Peptide Aus, from Australian stock: Sermorelin Acetate (10mg) is $239.99 AUD including GST. Paid orders before 2pm AEST/AEDT dispatch the same business day, tracked.